Keros Therapeutics, Inc. (KROS)
Lexington, MA
Total Compensation for Fiscal Year Ending in 2024: $6,273,192
| Salary | $699,039 |
|---|---|
| Bonus | $0 |
| Value of Stock Awards | $0 |
| Value of Option Awards | $5,104,488 |
| Non-Equity Incentive Plan Compensation | $455,000 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $14,666 |
| Total | $6,273,192 |
Keros Therapeutics, Inc. disclosed its CEO pay was
17
times its median employee's pay for the fiscal year ending in 2024.
How Do You Compare?
